vs
Side-by-side financial comparison of Enhabit, Inc. (EHAB) and STONERIDGE INC (SRI). Click either name above to swap in a different company.
Enhabit, Inc. is the larger business by last-quarter revenue ($270.4M vs $205.2M, roughly 1.3× STONERIDGE INC). On growth, Enhabit, Inc. posted the faster year-over-year revenue change (4.7% vs -6.0%). Enhabit, Inc. produced more free cash flow last quarter ($3.3M vs $2.6M). Over the past eight quarters, Enhabit, Inc.'s revenue compounded faster (1.5% CAGR vs -7.4%).
Enhabit, Inc., is a Dallas, Texas-based provider of home health and hospice services. The company operates 255 home health and 110 hospice locations in 34 states with a concentration in Texas, Alabama, Florida, Georgia, Oklahoma and Mississippi. Enhabit is the fourth-largest provider of home health services in the United States and is a leading provider of hospice services. The company was formed in 2022 when Encompass Health spun off its home health and hospice business.
Stoneridge Inc is a global designer and manufacturer of advanced electrical and electronic components, integrated systems, and sensor solutions. It serves automotive, commercial vehicle, off-highway, and aerospace sectors, delivering products that boost vehicle safety, efficiency, connectivity, and environmental performance across key global markets.
EHAB vs SRI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.4M | $205.2M |
| Net Profit | $-38.7M | — |
| Gross Margin | — | 16.2% |
| Operating Margin | -12.3% | -14.4% |
| Net Margin | -14.3% | — |
| Revenue YoY | 4.7% | -6.0% |
| Net Profit YoY | 15.9% | — |
| EPS (diluted) | $-0.76 | $-2.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.4M | $205.2M | ||
| Q3 25 | $263.6M | $210.3M | ||
| Q2 25 | $266.1M | $228.0M | ||
| Q1 25 | $259.9M | $217.9M | ||
| Q4 24 | $258.2M | $218.2M | ||
| Q3 24 | $253.6M | $213.8M | ||
| Q2 24 | $260.6M | $237.1M | ||
| Q1 24 | $262.4M | $239.2M |
| Q4 25 | $-38.7M | — | ||
| Q3 25 | $11.1M | $-9.4M | ||
| Q2 25 | $5.2M | $-9.4M | ||
| Q1 25 | $17.8M | $-7.2M | ||
| Q4 24 | $-46.0M | — | ||
| Q3 24 | $-110.2M | $-7.1M | ||
| Q2 24 | $-200.0K | $2.8M | ||
| Q1 24 | $200.0K | $-6.1M |
| Q4 25 | — | 16.2% | ||
| Q3 25 | — | 20.3% | ||
| Q2 25 | — | 21.5% | ||
| Q1 25 | — | 21.2% | ||
| Q4 24 | — | 19.5% | ||
| Q3 24 | — | 20.8% | ||
| Q2 24 | — | 22.7% | ||
| Q1 24 | — | 20.2% |
| Q4 25 | -12.3% | -14.4% | ||
| Q3 25 | 6.4% | -1.6% | ||
| Q2 25 | 6.3% | -1.1% | ||
| Q1 25 | 6.1% | -1.5% | ||
| Q4 24 | -16.0% | -2.0% | ||
| Q3 24 | -38.6% | 0.1% | ||
| Q2 24 | 4.3% | 1.4% | ||
| Q1 24 | 4.9% | 0.1% |
| Q4 25 | -14.3% | — | ||
| Q3 25 | 4.2% | -4.5% | ||
| Q2 25 | 2.0% | -4.1% | ||
| Q1 25 | 6.8% | -3.3% | ||
| Q4 24 | -17.8% | — | ||
| Q3 24 | -43.5% | -3.3% | ||
| Q2 24 | -0.1% | 1.2% | ||
| Q1 24 | 0.1% | -2.6% |
| Q4 25 | $-0.76 | $-2.76 | ||
| Q3 25 | $0.22 | $-0.34 | ||
| Q2 25 | $0.10 | $-0.34 | ||
| Q1 25 | $0.35 | $-0.26 | ||
| Q4 24 | $-0.92 | $-0.22 | ||
| Q3 24 | $-2.20 | $-0.26 | ||
| Q2 24 | $0.00 | $0.10 | ||
| Q1 24 | $0.01 | $-0.22 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $43.6M | $66.3M |
| Total DebtLower is stronger | $426.0M | $180.9M |
| Stockholders' EquityBook value | $534.0M | $179.8M |
| Total Assets | $1.2B | $551.2M |
| Debt / EquityLower = less leverage | 0.80× | 1.01× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $43.6M | $66.3M | ||
| Q3 25 | $56.9M | $54.0M | ||
| Q2 25 | $37.1M | $49.8M | ||
| Q1 25 | $39.5M | $79.1M | ||
| Q4 24 | $28.4M | $71.8M | ||
| Q3 24 | $45.7M | $54.1M | ||
| Q2 24 | $28.5M | $42.1M | ||
| Q1 24 | $36.5M | $48.4M |
| Q4 25 | $426.0M | $180.9M | ||
| Q3 25 | $441.5M | — | ||
| Q2 25 | $456.9M | — | ||
| Q1 25 | $467.3M | — | ||
| Q4 24 | $492.6M | $201.6M | ||
| Q3 24 | $502.9M | — | ||
| Q2 24 | $512.7M | — | ||
| Q1 24 | $526.7M | — |
| Q4 25 | $534.0M | $179.8M | ||
| Q3 25 | $566.8M | $251.2M | ||
| Q2 25 | $552.4M | $260.5M | ||
| Q1 25 | $543.2M | $253.1M | ||
| Q4 24 | $523.5M | $245.3M | ||
| Q3 24 | $566.1M | $271.4M | ||
| Q2 24 | $674.3M | $270.5M | ||
| Q1 24 | $672.3M | $277.3M |
| Q4 25 | $1.2B | $551.2M | ||
| Q3 25 | $1.2B | $632.1M | ||
| Q2 25 | $1.2B | $639.4M | ||
| Q1 25 | $1.2B | $657.4M | ||
| Q4 24 | $1.2B | $621.6M | ||
| Q3 24 | $1.3B | $662.5M | ||
| Q2 24 | $1.4B | $666.7M | ||
| Q1 24 | $1.4B | $675.4M |
| Q4 25 | 0.80× | 1.01× | ||
| Q3 25 | 0.78× | — | ||
| Q2 25 | 0.83× | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | 0.94× | 0.82× | ||
| Q3 24 | 0.89× | — | ||
| Q2 24 | 0.76× | — | ||
| Q1 24 | 0.78× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.4M | $8.8M |
| Free Cash FlowOCF − Capex | $3.3M | $2.6M |
| FCF MarginFCF / Revenue | 1.2% | 1.3% |
| Capex IntensityCapex / Revenue | 0.4% | 3.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $65.8M | $12.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.4M | $8.8M | ||
| Q3 25 | $37.8M | $3.6M | ||
| Q2 25 | $10.6M | $10.7M | ||
| Q1 25 | $17.9M | $10.9M | ||
| Q4 24 | $-4.1M | $19.2M | ||
| Q3 24 | $28.4M | $10.8M | ||
| Q2 24 | $9.6M | $8.7M | ||
| Q1 24 | $17.3M | $9.1M |
| Q4 25 | $3.3M | $2.6M | ||
| Q3 25 | $36.2M | $-2.7M | ||
| Q2 25 | $8.7M | $7.4M | ||
| Q1 25 | $17.6M | $4.8M | ||
| Q4 24 | $-4.7M | $14.0M | ||
| Q3 24 | $27.7M | $4.6M | ||
| Q2 24 | $8.9M | $1.5M | ||
| Q1 24 | $15.5M | $3.3M |
| Q4 25 | 1.2% | 1.3% | ||
| Q3 25 | 13.7% | -1.3% | ||
| Q2 25 | 3.3% | 3.3% | ||
| Q1 25 | 6.8% | 2.2% | ||
| Q4 24 | -1.8% | 6.4% | ||
| Q3 24 | 10.9% | 2.2% | ||
| Q2 24 | 3.4% | 0.6% | ||
| Q1 24 | 5.9% | 1.4% |
| Q4 25 | 0.4% | 3.0% | ||
| Q3 25 | 0.6% | 3.0% | ||
| Q2 25 | 0.7% | 1.4% | ||
| Q1 25 | 0.1% | 2.8% | ||
| Q4 24 | 0.2% | 2.4% | ||
| Q3 24 | 0.3% | 2.9% | ||
| Q2 24 | 0.3% | 3.0% | ||
| Q1 24 | 0.7% | 2.4% |
| Q4 25 | — | — | ||
| Q3 25 | 3.41× | — | ||
| Q2 25 | 2.04× | — | ||
| Q1 25 | 1.01× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.11× | ||
| Q1 24 | 86.50× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
SRI
| Control Devices | $51.7M | 25% |
| Electronics | $38.0M | 19% |
| EE | $34.2M | 17% |
| SE | $28.6M | 14% |
| NL | $24.5M | 12% |
| Stoneridge Brazil | $14.1M | 7% |
| Asia Pacific | $13.1M | 6% |
